Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects
Watford WT et al. Immunol Rev. 2004;202:139-156.
Tokarski JS et al. J Biol Chem. 2015;290:11061-11074.
Volpe E et al. Nat Immunol. 2008;9:650-657.
Geremia A et al. J Exp Med. 2011;208:1127-1133.
Tucci M et al. Clin Exp Immunol. 2008;154:247-254.
Lazear HM et al. Immunity. 2015;21:15-28.
Papp K et al. N Engl J Med. 2018;379:1313-1321.
Abstract - 92 Poster PDF - 35
- There are currently no refbacks.